Isabelle Aerts Selected Research

Cell-Free Nucleic Acids

9/2023	Diffuse Infiltrating Retinoblastoma with Anterior Chamber Involvement: Conservative Management and Identification of RB1 Alterations in Aqueous Humor.
1/2022	The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies.
12/2021	Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and Biomarkers.
1/2021	Molecular diagnosis of retinoblastoma by circulating tumor DNA analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isabelle Aerts Research Topics

Disease

52	Neoplasms (Cancer) 02/2024 - 12/2003
23	Retinoblastoma (Glioblastoma, Retinal) 09/2023 - 07/2004
9	Glioma (Gliomas) 09/2023 - 01/2011
5	Medulloblastoma 01/2023 - 09/2013
5	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2011
5	Neoplasm Metastasis (Metastasis) 10/2021 - 12/2011
4	Neuroblastoma 03/2024 - 01/2006
4	Hepatoblastoma 03/2024 - 02/2017
3	Rhabdomyosarcoma 04/2024 - 12/2003
3	Thrombocytopenia (Thrombopenia) 12/2023 - 10/2010
2	Drug-Related Side Effects and Adverse Reactions 03/2024 - 01/2023
2	Neutropenia 12/2023 - 10/2010
2	Central Nervous System Neoplasms 01/2023 - 01/2020
2	Genetic Predisposition to Disease (Genetic Predisposition) 12/2021 - 01/2020
2	Disease Progression 01/2021 - 01/2020
2	Margins of Excision 01/2021 - 04/2013
2	Ewing Sarcoma (Sarcoma, Ewing) 01/2016 - 12/2011
1	Hepatocellular Carcinoma (Hepatoma) 03/2024
1	Exanthema (Rash) 03/2023
1	Hyponatremia 01/2023
1	Craniopharyngioma (Craniopharyngiomas) 01/2023
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Toxic Optic Neuropathy 01/2022
1	Hypothyroidism 01/2022
1	Thyroid Nodule (Nodule, Thyroid) 01/2022
1	Liver Neoplasms (Liver Cancer) 10/2021
1	Cicatrix (Scar) 01/2021

Drug/Important Bio-Agent (IBA)

7	Temozolomide (Temodar)FDA LinkGeneric 03/2024 - 10/2010
5	Carboplatin (JM8)FDA LinkGeneric 12/2023 - 08/2008
5	Biomarkers (Surrogate Marker)IBA 12/2023 - 05/2017
5	Topotecan (Hycamtin)FDA LinkGeneric 11/2021 - 10/2010
4	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 12/2021
4	Cell-Free Nucleic AcidsIBA 09/2023 - 01/2021
3	Cisplatin (Platino)FDA LinkGeneric 02/2024 - 12/2003
3	dabrafenibIBA 09/2023 - 12/2019
3	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 12/2003
3	Retinaldehyde (Retinal)IBA 01/2021 - 01/2017
3	Irinotecan (Camptosar)FDA LinkGeneric 10/2020 - 07/2012
2	RNA (Ribonucleic Acid)IBA 04/2024 - 07/2023
2	NivolumabIBA 01/2024 - 01/2021
2	Vincristine (Oncovin)FDA LinkGeneric 09/2023 - 12/2003
2	trametinibIBA 09/2023 - 01/2023
2	Phosphotransferases (Kinase)IBA 07/2023 - 03/2023
2	Circulating Tumor DNAIBA 10/2022 - 01/2021
2	SuspensionsIBA 01/2022 - 01/2017
2	Sirolimus (Rapamycin)FDA Link 11/2021 - 10/2020
2	Ifosfamide FDA LinkGeneric 01/2021 - 12/2003
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 12/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 07/2012
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2020
2	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 07/2017
2	Bevacizumab (Avastin)FDA Link 09/2016 - 07/2012
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2010 - 09/2009
1	dinutuximabIBA 03/2024
1	AntibodiesIBA 03/2024
1	SolutionsIBA 03/2024
1	CateninsIBA 02/2024
1	antineoplaston A10 (A 10)IBA 01/2024
1	adavosertibIBA 12/2023
1	TropomyosinIBA 07/2023
1	Celecoxib (Celebrex)FDA Link 03/2023
1	Fluvastatin FDA Link 03/2023
1	CreatineIBA 03/2023
1	talimogene laherparepvecIBA 01/2023
1	AfatinibIBA 01/2023
1	Growth Hormone (Somatotropin)IBA 01/2023
1	CytokinesIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	TabletsIBA 01/2022
1	Macrophage Migration-Inhibitory FactorsIBA 01/2022
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2022
1	Conditioned Culture MediaIBA 01/2022
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	cobimetinibIBA 01/2022
1	Everolimus FDA Link 11/2021
1	ribociclibIBA 11/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2021
1	vistusertibIBA 11/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021

Therapy/Procedure

21	Therapeutics 12/2023 - 12/2003
18	Drug Therapy (Chemotherapy) 03/2024 - 12/2003
14	Radiotherapy 01/2023 - 12/2003
10	Investigational Therapies (Experimental Therapy) 01/2023 - 01/2011
5	Conservative Treatment 09/2023 - 08/2008
3	Neoadjuvant Therapy 02/2024 - 08/2008
2	Immunotherapy 03/2024 - 01/2023
2	Salvage Therapy 01/2022 - 01/2011
2	Adjuvant Chemotherapy 01/2021 - 04/2013
2	Induced Hyperthermia (Thermotherapy) 04/2015 - 08/2008
2	Aftercare (After-Treatment) 05/2013 - 05/2009
2	Photochemotherapy (Photodynamic Therapy) 12/2010 - 09/2009
1	Off-Label Use 03/2024
1	Pituitary Irradiation 01/2022
1	Precision Medicine 01/2022